ATRA

Conviction 14HealthcareScan · Mon, Aug 10, 2026

Three inside up

ATRA$8.65+2.37%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 47.47K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Atara Biotherapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.atarabio.com ↗

Price8.65

Change+2.37%

Gap+0.41%

Rel volume0.33×

Avg volume58.52K

Avg $ vol481.51K

SMA 208.31

SMA 509.48

SMA 2009.22

Price vs 50-8.75%

Price vs 200-6.20%

MA stackmixed

50/200 cross—

Supertrenddown · 9.69

RSI (14)49

MACD hist0.10

MACD crossbull · 5d

Stoch %K / %D73 / 62

ADX (14)21

+DI / −DI18 / 20

RSI divergenceBullish

MACD divergenceBullish

ATR %+6.99%

ADR %6.92%

52w high18.09

52w low4.18

From 52w high-52.18%

Above 52w low+106.94%

New 52w highNo

SqueezeOn · 2d

Bollinger width14.39%

%B0.79

Donchian pos73.26%

Donchian high9.11

Donchian low7.39

AVWAP (52w high)8.79

vs AVWAP high-1.59%

AVWAP (52w low)9.14

vs AVWAP low-5.39%

OBV trendFlat

Chaikin MF (20)-0.04

Today vs 20d0.33×

Avg vol (14d)47.47K

Avg vol (20d)58.52K

Avg $ vol (20d)481.51K

Market cap77.94M

RS 3m (vs SPY)-20.60%

RS 6m (vs SPY)+73.25%

RS line new highNo

Trend template1/8

Technical rank48.2

1 week+1.17%

1 month-11.37%

3 months+3.72%

6 months+77.25%

1 year-21.08%

YTD-51.32%

P/E2.38

P/B-2.09

P/S0.65

P/FCF-1.53

EPS2.57

Div yield—

ROE-87.61%

ROA163.46%

Debt/Eq—

Current2.16

EV/EBITDA1.83

Gross margin—

Net margin27.07%

Rev growth-6.33%

EPS growth138.28%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value69.58M

Revenue516K

Net income-4.14M

Gross profit—

Free cash flow-50.94M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out9.01M

Employees13

ListedThu, Oct 16, 2014

Free float2.59M

Float %36.0%

Short interest577.63K

Days to cover6.2d

Short volume39.9%

Squeeze score65 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.29

Last surprise—

Setup gradeD

Conviction14 / 100

Pattern quality—

Tech rank48.2 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmThree inside up

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ATRA

All disclosures →

No recent disclosed trades by Congress in ATRA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ATRA · 1 buy · 4 sells

Insider	Side	Shares	Value	Traded	Filed
Nguyen AnhCo President and CEO · Common Stock · 2026-05-18	Sell	5.24K	$48K	2026-05-18	2026-05-20
Grant-Huerta Yanina Chief Accounting Officer · Common Stock · 2026-05-18	Sell	2.41K	$22K	2026-05-18	2026-05-20
EcoR1 Capital, LLC 10% owner · Common Stock · 2026-05-07	Buy	507.41K	$4.7M	2026-05-07	2026-05-11
Panacea Innovation Ltd 10% owner · Common Stock · 2026-05-07	Sell	313.45K	$3.2M	2026-05-07	2026-05-11
Huang James Director · Common Stock · 2026-05-07	Sell	313.45K	$3.2M	2026-05-07	2026-05-11
Panacea Innovation Ltd 10% owner · Common Stock · 2026-05-07	Other	—	—	2026-05-07	2026-05-11
Huang James Director · Common Stock · 2026-05-07	Other	—	—	2026-05-07	2026-05-11

SEC filings

EDGAR filings in ATRA · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.